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ABSTRACT 
 
 
 
 
Alpha-mangostin has been identified as a potent anti-melanogenesis 
compound in vitro on B16F1 melanoma cells. A concentration of 5 µg/mL 
demonstrated promising anti-melanogenesis effect without compromising the cell 
viability. However, due to its high lipophilic nature, the cosmeceutical application of 
α-mangostin in topical formulation is restricted. The current investigation aimed to 
evaluate the potential of proniosome as a carrier to enhance skin permeation and skin 
retention of α-mangostin. Alpha-mangostin proniosomal formulations were prepared 
using coacervation phase separation method. Upon hydration, α-mangostin-loaded 
niosomes were characterized for size, polydispersity index, entrapment efficiency, 
zeta potential and morphology. Using different surfactants, preliminary study to 
evaluate skin concentration suggested that Spans significantly (p < 0.05) enhanced 
deposition of α-mangostin in the viable epidermis/dermis layer (VED) as compared 
to Tween 60. Incorporation of soya lecithin in the proniosomal formulation also 
significantly enhanced the VED concentration of α-mangostin. The in vitro 
permeation experiments using dermis-split Yucatan Micropig skin revealed that 
proniosomes composed of Spans, soya lecithin and cholesterol were able to enhance 
the skin permeation of α-mangostin with a factor range from 1.8 to 8.0-fold as 
compared to the control suspension. All the proniosomal formulations (except for 
S20L) had significantly (p < 0.05) enhanced the deposition of α-mangostin in the 
VED layer with a factor range from 2.5 to 2.9-fold as compared to the control 
suspension. Proniosome S85L showed the highest permeation profile (8.0-fold) and 
the highest enhancement of VED concentration of α-mangostin (2.9-fold). 
Collectively, these results suggested that proniosomes can be utilized as a promising 
carrier for a highly lipophilic compound like α-mangostin. 
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ABSTRAK 
 
 
 
 
Alfa-mangostin telah dikenalpasti sebagai kompaun anti-melanogenesis yang 
kuat pada sel melanoma B16F1 in vitro. Kepekatan optimum 5 μg/ml menunjukkan 
kesan anti-melanogenesis tanpa menjejaskan kebolehidupan sel. Walau 
bagaimanapun, sifat α-mangostin yang sangat lipofilik telah mengehadkan 
aplikasinya dalam formulasi sediaan topikal kosmetik. Kajian ini bertujuan untuk 
menilai potensi proniosom sebagai sistem pembawa α-mangostin untuk 
meningkatkan kadar penyerapan dan kesampaiannya ke kulit. Formulasi proniosom 
α-mangostin telah disediakan dengan menggunakan kaedah pemisahan fasa 
koaservatan. Selepas proses penghidratan, niosom α-mangostin dicirikan menerusi 
saiz, indeks kepoliserakan, kecekapan perangkap, potensi zeta dan morfologi. Kajian 
awal menujukkan bahawa proniosom yang disediakan daripada surfaktan Span dapat 
menyampaikan α-mangostin ke lapisan epidermis/dermis yang hidrofilik (VED) 
dengan lebih berkesan berbanding dengan surfaktan Tween 60 (p < 0.05). Di 
samping itu, lesitin soya juga didapati meningkatkan prestasi pembawaan α-
mangostin ke lapisan VED (p < 0.05). Eksperimen penyerapan in vitro yang 
dijalankan dengan menggunakan kulit Yucatan Micropig yang terpisah lapisan 
dermisnya mendapati bahawa proniosom yang dihasilkan daripada Span, lesitin soya 
dan kolesterol dapat meningkatkan penyerapan α-mangostin di kulit (p < 0.05) lebih 
berkesan berbanding dengan kumpulan kawalan. Semua formulasi proniosom 
(kecuali S20L) menunjukkan keupayaan untuk meningkatkan kesampaian α-
mangostin ke lapisan VED sebanyak 2.5 – 2.9 kali ganda dengan perbezaan yang 
signifikan (p < 0.05) berbanding dengan kumpulan kawalan. Formulasi proniosom 
S85L menunjukkan penyerapan (8.0 kali ganda) dan pembawaan α-mangostin di 
lapisan VED (2.9 kali ganda) yang paling tinggi. Secara keseluruhannya, keputusan 
menunjukkan bahawa proniosom boleh digunakan sebagai pembawa bagi kompaun 
yang sangat lipofilik seperti α-mangostin. 
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CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Research Background  
 
 
To date, due to the increased awareness of consumer and the advancement of 
research and development (R&D), the cosmeceutical industries have switched their 
focus from the use of chemical derivatives to the use of natural products as 
cosmeceutical ingredient. However, there are several common problems associated 
with the development of cosmeceutical products using natural products, one being 
the poor permeation of the natural derivatives through the skin. It is a clear fact that 
no matter how powerful a natural compound is, it is useless unless the compound is 
effectively delivered to its targeted site for action.  
 
 
Mangosteen (Garcinia mangostana Linn.) which is native to Malaysia has 
been valued for a variety of bioactive compounds isolated from its edible plant parts, 
namely xanthones and phenolics (Karim and Azlan, 2012). Xanthones are of great 
interest to researchers as they exerted a wide range of remarkable bioactivities such 
as antioxidant, antimicrobial, antiviral, anti-cancer, and anti-inflammatory activities 
(Abdalrahim et al., 2012; Yoswathana, 2013). More than 50 xanthones have been 
isolated and α-mangostin is the major xanthone identified from the pericarp of 
mangosteen (Abdalrahim et al., 2012). A previous work (Mariani et al., 2014) 
reported that α-mangostin is a potent depigmenting agent due to its strong anti-
melanogenic activity, capable of inhibiting activity of tyrosinase enzyme and down-
regulating genes expression involved in the melanogenesis pathways. The study 
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suggested the potential of α-mangostin in the development of whitening range 
cosmeceutical products.  
 
 
Despite its strong biological activities, α-mangostin is a highly lipophilic 
compound, with an estimate log P value of 4.64 (ChemDraw Professional 15.0, 
Cambridge Soft, Perkin Elmer). Due to its poor water solubility, the permeation of α-
mangostin through the skin layers is very challenging. In order to overcome the skin 
permeation limitation by α-mangostin, proniosome, which is a potent colloidal type 
delivery system was chosen as a carrier vesicle to transport the α-mangostin to its 
skin targeted site. The melanocytes are located at the basal epidermis layer for anti-
melanogenesis activity.  
 
 
Coacervation phase separation method, a method for proniosomes preparation 
was employed in this study. This method works under simple idea that the mixture of 
surfactant: alcohol: aqueous phase can be used to form the concentrated proniosomal 
formulation, which upon dilution with excess aqueous phase will convert 
spontaneously to a stable niosomal dispersion (Vora et al., 1998). This method 
allows easy future scale up of production as it is simple and practical for routine, 
does not involved lengthy procedures, does not required expensive instrumentations, 
and does not involved the unnecessary use of organic solvent and unacceptable 
additives (Vora et al., 1998; Fang et al., 2001). The main ingredient of proniosome 
was non-ionic surfactant while others ingredients (i.e. cholesterol and soya lecithin) 
were added to enhance the vesicle stability and skin permeability.  
 
 
 
 
1.2 Problem Statement 
 
 
Alpha-mangostin has been identified as a potent depigmenting compound that 
suitable to be incorporated in whitening range cosmeceutical products. Despite its 
potent anti-melanogenic activity, application of α-mangostin in topical cosmeceutical 
is restricted due to its high lipophilicity and poor water solubility.  
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Lipophilicity is one of the important descriptor governing drug permeation 
across a biological membrane (Malkia et al., 2004). Lipophilicity is generally 
expressed quantitatively as the log10 of the partitioning of a neutral drug species 
between n-octanol and water (log Ko/w or log P). Skin permeation of compounds was 
reported to be increased with lipophilicity. However, a further increase in log P to 
more than 4.1 was reported to decrease the skin permeability. Alpha-mangostin is 
highly lipophilic (log P = 4.64), therefore the permeation of α-mangostin through the 
rate-limiting skin membrane is very challenging and thus needs to be overcome. 
 
 
This study was proposed to develop a convenient and low-cost transdermal 
drug delivery for α-mangostin using proniosome as a novel carrier. Several non-
irritant, non-toxic, and relatively cheap non-ionic surfactants were screened for α-
mangostin proniosome preparations. Since the development of proniosome still in its 
infancy, therefore further exploration is required to study the factors that could 
influence the characteristics and performance of proniosome. The influence of 
formulation components on the characteristics of α-mangostin proniosome such as 
vesicle size, polydispersity index (PDI), encapsulation efficiency (EE), zeta potential 
and morphology were investigated. Furthermore, the in vitro permeation and skin 
retention of α-mangostin proniosome were also studied using dermis-split Yucatan 
Micropig (YMP) skin. 
 
 
 To date, no report was found on the development of α-mangostin proniosome 
using coacervation phase separation method (a recently developed method). Also, no 
report was found reporting the in vitro permeation and skin retention of α-mangostin 
through the non-viable skin, hence the novelty of this study. 
 
 
 
 
1.3 Hypothesis 
 
 
Due to the highly lipophilic nature of α-mangostin, the compound might tend 
to accumulate in the outermost layer of skin (hydrophobic stratum corneum) and has 
limited permeation across the lower layers (the hydrophilic viable epidermis/dermis 
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or VED), thereby results in reduced bioavailability and therapeutic effect of the 
compounds. In this study, the α-mangostin proniosomes were developed to enhance 
topical delivery. Proniosomes improved permeation flux of α-mangostin across the 
skin and increased the skin retention of α-mangostin in the viable epidermis /dermis 
(VED) layer where the melanocytes (pigment forming cells) are located. Furthermore, 
the formulation aspects of proniosome play a major role in determining the 
characteristics and performance of α-mangostin proniosomes.  
 
 
 
 
1.4 Research Objectives 
 
 
1.4.1 To develop and characterize the α-mangostin proniosome. 
1.4.2 To determine the in vitro permeation and skin retention of α-mangostin 
proniosome. 
 
 
 
 
1.5 Scopes of Study 
 
 
In order to achieve the objectives, scopes of the study had been identified and 
narrowed down. This research covered the scopes of study as listed as following: 
 
 
1.5.1 Screening of formulation ingredients of α-mangostin proniosome based on 
solubility and preliminary skin retention study. Development of α-mangostin 
proniosome by using coacervation phase separation method. Formulation 
ingredients including the non-ionic surfactants (Spans and Tweens), 
cholesterol and soya lecithin. Characterization of the α-mangostin 
proniosome in term of size, polydispersity index (PDI), entrapment efficiency 
(EE), zeta potential and morphology. 
 
 
1.5.2 In vitro permeation study and skin retention study of α-mangostin 
proniosome through dermis-split Yucatan Micropig (YMP) skin (48h). 
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Determine the concentration of α-mangostin retained in the stratum corneum 
and the viable epidermis-dermis layer (VED) (refers to as the ‘total 
concentration’) and the concentration of α-mangostin retained in the tap-
stripped skin (refers to as the ‘VED concentration’). 
 
 
1.5.3 Determine the effect of formulation ingredients on the characteristics and 
performance (in vitro permeation and skin retention) of α-mangostin 
proniosome. 
 
 
 
 
1.6 Significances of Study 
 
 
This study developed a novel topical delivery system (proniosome) of α-
mangostin with enhanced in vitro skin permeation and skin retention in the viable 
epidermis/dermis (VED) layer (which is the targeting site for anti-melanogenesis 
activity), critical for cosmeceutical application. The developed α-mangostin 
proniosomal formulations provide a good ingredient for whitening cosmeceuticals 
(e.g. whitening serum, cream etc.), thus promoting the use of local herbs as an 
ingredient for cosmeceutical application. Besides, data concerning the development, 
characterization, in vitro permeation and skin retention of α-mangostin through the 
non-viable skin could provide useful literature for researchers working in 
cosmeceutical and pharmaceutical areas, as α-mangostin was also reported to exhibit 
a variety of bioactivities. The data regarding the effect of formulation ingredients on 
the characteristics and performance of vesicles could also provide useful references 
for formulation development, optimization, and scaling up in future.  
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